LIR-containing proteins in Mus musculus>> EXPORT DATA
S.No. | Uniprot ID | Start | End | LIR Sequence | PSSM Score ▲ ▼ | Similar LIR Motifs | Molecular Function | Biological Process | Cellular Component |
2101 | Q3TZY4 | 234 | 239 | AEYLKL | 12 | ||||
2102 | Q3U021 | 106 | 111 | FDYLTL | 17 | ||||
2103 | Q3U0J8 | 252 | 257 | EEWELL | 20 | STBD1_HUMAN(201-206) EEWEMV(4); TBCD5_HUMAN(57-62) KEWEEL(4) |
|||
2104 | Q3U0X6 | 590 | 595 | SVFQSV | 6 | ||||
2105 | Q3U1C4 | 390 | 395 | PSYEVL | 13 | FUND1_HUMAN(16-21) DSYEVL(5) | protein binding (GO:0005515); ribonucleoprotein complex binding (GO:0043021) |
mitochondrion (GO:0005739); ribonucleoprotein complex (GO:0030529) |
|
2106 | Q3U1F9 | 384 | 389 | PDYEAI | 16 | protein binding (GO:0005515) |
immune system process (GO:0002376) |
||
2107 | Q3U1F9 | 412 | 417 | SDYESI | 17 | protein binding (GO:0005515) |
immune system process (GO:0002376) |
||
2108 | Q3U1M7 | 576 | 581 | DVYTAV | 9 | ||||
2109 | Q3U1V8 | 637 | 642 | PGFTSL | 10 | ||||
2110 | Q3U1V8 | 735 | 740 | LGFDLL | 10 | ||||
2111 | Q3U214 | 733 | 738 | SEFLAV | 11 | ||||
2112 | Q3U280 | 400 | 405 | SSFEDL | 12 | ||||
2113 | Q3U3D7 | 1149 | 1154 | DSFEPV | 13 | ||||
2114 | Q3U3D7-2 | 1149 | 1154 | DSFEPV | 13 | ||||
2115 | Q3U3D7-3 | 1148 | 1153 | DSFEPV | 13 | ||||
2116 | Q3U3M5 | 444 | 449 | EGYQSL | 12 | ||||
2117 | Q3U3N6 | 253 | 258 | GGWDEL | 19 | ||||
2118 | Q3U3T8 | 947 | 952 | PSYLPL | 11 | nucleus (GO:0005634) |
|||
2119 | Q3U3T8-2 | 947 | 952 | PSYLPL | 11 | ||||
2120 | Q3U3T8-3 | 925 | 930 | PSYLPL | 11 | ||||
2121 | Q3U3V8 | 608 | 613 | DGYEEL | 16 | FUND1_HUMAN(16-21) DSYEVL(4) | nucleus (GO:0005634) |
||
2122 | Q3U432 | 158 | 163 | AGFELL | 11 | ||||
2123 | Q3U4W8 | 126 | 131 | PDYLEI | 16 | protein binding (GO:0005515) |
|||
2124 | Q3U8K7 | 845 | 850 | DDFIPL | 17 | ||||
2125 | Q3U8K7-3 | 822 | 827 | DDFIPL | 17 | ||||
2126 | Q3UCG9 | 164 | 169 | LVFLVL | 6 | ||||
2127 | Q3UDE2 | 24 | 29 | DEFVSL | 15 | cellular protein modification process (GO:0006464) |
|||
2128 | Q3UE17 | 433 | 438 | FGFDFL | 13 | nucleus (GO:0005634) |
|||
2129 | Q3UE17-2 | 400 | 405 | FGFDFL | 13 | ||||
2130 | Q3UE37 | 310 | 315 | FDYQSL | 16 | nucleus (GO:0005634) |
|||
2131 | Q3UEN2 | 229 | 234 | AEFLSV | 10 | ||||
2132 | Q3UF64 | 44 | 49 | GVFESL | 7 | ||||
2133 | Q3UF64-2 | 45 | 50 | GVFESL | 7 | ||||
2134 | Q3UF95 | 1020 | 1025 | PEWVPI | 19 | Q9SB64_ARATH(659-664) SEWDPI(4) | protein binding (GO:0005515) |
nucleus (GO:0005634) |
|
2135 | Q3UFK8 | 451 | 456 | GSYTVV | 11 | cytoskeleton (GO:0005856) |
|||
2136 | Q3UFM6 | 165 | 170 | ASFQEI | 11 | OPTN_HUMAN(176-181) DSFVEI(4) | nucleus (GO:0005634) |
||
2137 | Q3UFY0 | 121 | 126 | KTYQFL | 12 | nucleolus (GO:0005730) |
|||
2138 | Q3UGX8 | 135 | 140 | RVYQSL | 8 | signal transducer activity (GO:0004871) |
intracellular (GO:0005622) |
||
2139 | Q3UGX8 | 365 | 370 | PDYEFL | 17 | CLH1_HUMAN(512-517) PDWIFL(4) | signal transducer activity (GO:0004871) |
intracellular (GO:0005622) |
|
2140 | Q3UGX8 | 740 | 745 | DEYVSL | 16 | signal transducer activity (GO:0004871) |
intracellular (GO:0005622) |
||
2141 | Q3UH28 | 556 | 561 | DVYTAV | 9 | ||||
2142 | Q3UH68 | 200 | 205 | DSFDSL | 14 | ||||
2143 | Q3UH68-2 | 44 | 49 | DSFDSL | 14 | ||||
2144 | Q3UH70 | 818 | 823 | SVFDPI | 8 | FYCO1_HUMAN(1278-1283) AVFDII(4); Q9SB64_ARATH(659-664) SEWDPI(4) |
chromatin binding (GO:0003682); protein binding (GO:0005515) |
chromosome segregation (GO:0007059) |
nucleus (GO:0005634) |
2145 | Q3UH85 | 380 | 385 | GSYDSI | 12 | ||||
2146 | Q3UHC1 | 403 | 408 | PDYEFL | 17 | CLH1_HUMAN(512-517) PDWIFL(4) | signal transducer activity (GO:0004871) |
||
2147 | Q3UHC7 | 1057 | 1062 | EEYETL | 15 | protein binding (GO:0005515) |
cell cycle (GO:0007049) |
neuronal cell body (GO:0043025) |
|
2148 | Q3UHC7-2 | 933 | 938 | EEYETL | 15 | ||||
2149 | Q3UHC7-3 | 1006 | 1011 | EEYETL | 15 | ||||
2150 | Q3UHC7-4 | 1029 | 1034 | EEYETL | 15 |